Merck gets CDSCO Panel Nod To study anti-cancer drug Avelumab
New Delhi: The drug major Merck has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct a non-interventional study (NIS) of Avelumab concentrate for solution for infusion (Intravenous Infusion) in India. This came after the drug maker Merck presented the proposal to conduct an interventional […]